Pre-eclampsia is a serious pregnancy-specific hypertensive disorder diagnosed after 20 weeks of gestation with new-onset hypertension (≥140/90 mmHg) and proteinuria or end-organ dysfunction. Monitor blood pressure at home using a validated device and follow a DASH diet to help manage BP. Seek immediate medical attention for BP ≥160/110 mmHg or consistent readings ≥140/90 mmHg.
January 14, 2025

Pre-Eclampsia and Gestational Hypertension Monitoring Tips

Evidence-Based Over-The-Counter Guide

William Shen

William Shen

Co-founder & CPO

See all guides. Have more questions?

Pre-eclampsia is a pregnancy-specific hypertensive disorder characterized by new-onset hypertension and end-organ dysfunction after 20 weeks of gestation. It poses risks to both maternal and fetal health. The exact pathophysiology remains unclear, but it is believed to involve abnormal placental development and endothelial dysfunction.

Diagnosis Criteria:

  • Systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg on two occasions, at least 4 hours apart, in a previously normotensive woman.

  • Proteinuria ≥300 mg/24 hours, protein/creatinine ratio ≥0.3, or dipstick 1+.

  • In the absence of proteinuria, end-organ dysfunction such as thrombocytopenia, renal insufficiency, liver dysfunction, pulmonary edema, or neurological symptoms can confirm the diagnosis.

First-line recommendations:

  • Monitor blood pressure: A home blood pressure monitor is the gold standard in tracking BP trends, outperforming sporadic in-office measurements if a validated device is used. OMRON Bronze Upper Arm Blood Pressure Monitor (FDA Reg. 1450057).

  • DASH Diet (Dietary Approaches to Stop Hypertension): A heart-healthy diet emphasizing fruits, vegetables, whole grains, lean proteins, and low-fat dairy while reducing sodium intake (<2300 mg/day) and limiting saturated fats and added sugars. The DASH diet is proven to lower blood pressure significantly by 10-20 mm Hg. Recommended DASH diet guide.

  • When to seek immediate medical attention: If blood pressure is ≥ 160 mm Hg systolic or ≥ 110 mm Hg diastolic or consistently ≥140/90 mmHg as complications of pre-eclampsia can be dangerous for both the fetus and the mother.

Professional management:

  • Delivery: The only definitive cure. Timing depends on gestational age and disease severity. 

  • Antihypertensive therapy: Doctors use agents safe during pregnancy, such as labetalol, nifedipine, or methyldopa

  • Magnesium sulfate: For seizure prophylaxis in severe pre-eclampsia. Loading dose 4-6 g IV over 20-30 minutes, followed by 1-2 g/hour IV infusion.

Citations:

Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020 Jun;135(6):e237-e260. doi: 10.1097/AOG.0000000000003891. PMID: 32443079.

What OTC evidence is reviewed?

  • For each condition, we performed a literature review to find a recent widely cited expert group guideline published in the leading specialty-specific peer-reviewed journal or top general medical journal.

  • Based on the recommendations in the publication, we identify recommended active ingredients and devices that are available over-the-counter per FDA regulations.

What evidence is prioritized?

Levels of evidence considered:

  • Tier 1 (Safe and Definitely Effective): Professional field consensus or multiple randomized controlled clinical trials showing the same conclusion. Wherever possible, we use Tier 1 evidence for "first-line" recommendations.

  • Tier 2 (Safe and Probably Effective): Individual clinical trials which may be discordant or large-scale observational experience. Tier 2 evidence may inform "first-line", "second-line", or "supplement" recommendations.

  • Tier 3 (Safe and Maybe Effective): Mechanistic plausibility without high-quality clinical evidence of efficacy but high-quality evidence of safety. Tier 3 evidence may inform "second-line" or "supplement" recommendations.

How does MDandMe select recommended products?

  • Based on the top clinical recommendation, we evaluate products containing the recommended active agent with FDA-approved dosage based on price, average customer reviews, how often it is purchased, and how quickly it will ship to home. 

  • We provide public documentation of the active ingredients in our recommendations, using all 32 FDA monographs, Prescription-to-Nonprescription (Rx-to-OTC) Switches, as well as New Drug Application (NDA) approvals.

How does MDandMe select recommended devices?

  • Based on the top clinical recommendation, we evaluate devices that are FDA-cleared or comply with other medical guidelines (if not a FDA-regulated category) by reputability, price, and average customer reviews.

  • We provide public documentation of supporting evidence for each device.